Hallmarks of Ageing: Focus on Iron Deregulation and Ageing | Prof Christiaan Leeuwenburgh

In this #webinar, Prof Christiaan Leeuwenburgh from the Department of Physiology and Ageing in University of Florida, United States, spoke about iron deregulation and ageing. His research focus is on understanding the molecular mechanisms of mitochondrial dysfunction, iron transport deregulation, autophagy and oxidative damage to Mt DNA in advanced age in animal models and humans.
Register for upcoming #HealthyLongevity #webinar sessions at bit.ly/3F0IlRd
#NUSMedicine #webinarseries
Closing video source:
• Art of Aging: Drexel n...
Disclaimer: The opinions and advice expressed in this webinar are those of the speakers and do not represent the views and opinions of the organizers and National University of Singapore or any of its subsidiaries or affiliates. The information provided in this webinar is for general information purposes only as part of a general discussion on public health. The information is not intended to be a substitute for professional medical advice, diagnoses or treatment; and cannot be relied on in place of consultation with your licensed healthcare provider. All Rights Reserved.

[@MichalTamas]

I love this webinar series! By any chance, is there any aging seminar, PhD course, or online course from NUS that can be taken from external people (students, PhDs, postdocs)? Thank you and keep up the good work!

[@yuvalkapellner2551]

One way to deal with it is draw blood monthly and just use it for prp for whatever you want- like hair growth boosting or skin improvement. By doing this draw every month, you will rid of some accumulated iron.

[@adrienmoyer]

Any datas on aging of hemochromatosis people? What would we expect, based on epidemiologic studies, for hemochromatosis patient with normal ferritin(~60-70ng/mL) moderately high Iron (>180ug/dL) and moderately high transferrin saturation (>50%)?

[@peterz53]

Can one use standard blood panels markers like hsCRP, ferritin, transferrin, etc to infer iron dysregulation? For example, is ferritin a useful marker of tissue accumulation and should we be looking to keep it towards low end of reference range?

[@gregorhirschfeld6293]

Prof Leeuwenburgh presented his research area very clearly and interesting. I enjoyed very much the Q and A section of this talk!

[@startingtoday4663]

re: Parkinson's patients with normal iron levels but with very low ferritin, would there be any benefit to introduce iron supplementation.